Comparing conventional and tailored limb lengths in gastric bypass surgery
Official title: Randomized Controlled Trial on Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery
Run by GEM Hospital & Research Center · NCT06756789 · Data updated 2026-11-12
This study is testing whether customizing the lengths of certain parts of gastric bypass surgery can help people lose more weight and improve their health compared to standard lengths.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | GEM Hospital & Research Center Academic / other |
| Locations | 1 site (Coimbatore, Tamil Nadu) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | May 31, 2025 |
| Study ends | December 2025 |
| Registry record updated | January 3, 2025 |
| Trial ID | NCT06756789 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-65 with a BMI of 40 kg/m² or higher, or 35 kg/m² with obesity-related comorbidities.
✕Probably not a fit
Patients with previous bariatric surgery or severe cardiopulmonary conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of tailoring limb lengths based on the 1/3rd and 2/3rd concept in Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) surgery. Participants are divided into two groups: one receiving conventional limb lengths of 75cm and 125cm, and the other receiving tailored limb lengths according to their total small bowel length. The study aims to assess total percentage weight loss, improvement in BMI, and remission of obesity-related comorbidities during the follow-up period.
Why it matters
Potential benefit: If successful, this approach could lead to improved weight loss outcomes and better management of obesity-related health issues for patients.
How similar studies have gone: While the concept of tailored limb lengths is innovative, similar studies have not been widely reported, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 18-65 years 2. Body Mass Index (BMI): BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with at least one obesity-related comorbidity (e.g., type 2 diabetes, hypertension, obstructive sleep apnea). 3. ASA - less than or equal to 3 4. Informed Consent: Ability and willingness to provide written informed consent and comply with procedures. 5. Previous Weight Loss Attempts: Documentation of previous attempts at weight loss through diet, exercise, or medical management. Exclusion Criteria: 1. Previous Bariatric Surgery: Prior bariatric or major gastrointestinal surgery that might affect the outcome of RYGB. 2. Severe Cardiopulmonary Conditions: Significant cardiac or pulmonary conditions that pose a high surgical risk (e.g., severe congestive heart failure, severe chronic obstructive pulmonary disease). 3. Uncontrolled Psychiatric Disorders: Severe psychiatric illness or substance abuse issues that are not well-controlled, including eating disorders. 4. Pregnancy: Current pregnancy or plans to become pregnant within 12 months post-surgery. 5. Malignancy: Active malignancy or history of malignancy requiring treatment in the past 5 years (excluding non-melanoma skin cancer). 6. Severe Liver Disease: Cirrhosis or significant liver dysfunction (e.g., Child-Pugh B or C). 7. Inability to Comply: Patients who are unable or unwilling to comply with the postoperative follow-up schedule and dietary requirements. 8. Chronic Use of Medications: Chronic use of medications known to affect weight or metabolism significantly, such as corticosteroids or antipsychotics. 9. Other Medical Conditions: Any other medical condition or surgical finding that, in the opinion of the investigators, would make the patient unsuitable for the study.
Where it's running
-
GEM Hospital and Research Center
Coimbatore, Tamil Nadu, India Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing the effects of bariatric arterial embolization and gastric bypass on obesity and diabetes
This study is testing whether a new procedure called bariatric arterial embolization can help people with obesity and Type 2 diabetes just as well as the traditional gastric bypass surgery.
-
Stress response with desflurane versus opioid-free TIVA during weight-loss surgery
This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.
-
Efsubaglutide alfa for weight loss after metabolic surgery
This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.
-
Evaluating anesthesia techniques for reducing inflammation in bariatric surgery
This study tests different anesthesia methods during bariatric surgery to see which one helps reduce inflammation and supports better recovery for patients.
-
Examining chronic pain improvement after weight loss surgery in specific ethnic groups
This study is testing if weight loss surgery can help reduce chronic pain in Hispanic/Latino and non-Hispanic Black adults with higher body weight.
-
Education to improve drinking habits and oral hygiene for people having bariatric surgery
This project will test three types of patient education—a custom website, clinician-led sessions, or free dental-hygiene samples—to see which best helps people having bariatric surgery improve drinking habits and oral care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.